Clinical trial
Effects of GLP-l Receptor Agonists on Cardiometabolic Alterations in HIV-associated Lipohypertrophy
NCT04019197 is registered in ClinicalTrials.gov with Case Western Reserve University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of GLP-l Receptor Agonists on Cardiometabolic Alterations in HIV-associated Lipohypertrophy
- Lead sponsor
- Case Western Reserve University
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- May 16, 2019
- Completion date
- September 1, 2026
- Enrollment
- 108 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hiv/aids, lipohypertrophy, obesity